IRCT2015052112724N2已完成未知
Randomized controlled trial for evaluation of safety and efficacy of topical cyclosporine 2% versus topical prednisolone for treatment of herpetic interstitial keratitis
Vice chancellor for research, Isfahan University of Medical Sciences0 个研究点目标入组 48 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 48
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16 years 至 75 years（—）
- 性别
- All
入选标准
- •Diagnosis of herpetic interstitial keratitis, No history of treatment with any form of immunosuppressant drugs one month before intervention, No history of diabetes mellitus, No history of co-existing viral disease.
- •Exclusion criteria: Any side effect attributable to study, patients who have not used drugs regularly, patients who have not come for follow up visits.
排除标准
- 未提供
研究者
相似试验
招募中
3 期
A random allocation study to receive one of the trial intervention, to evaluate the safety of breast conserving surgery (surgery to remove cancer while leaving as much normal breast as possible) after giving neo adjuvant therapy in patients with locally advanced breast cancer (large tumors).CTRI/2018/07/014767Tata Memorial Centre
招募中
不适用
A randomized controlled trial to evaluate the safety and efficacy of an 8-week home-based standardized exercise training program for preventing post-pulmonary embolism syndrome: the PE@HOME studypulmonary embolismNL-OMON54292eids Universitair Medisch Centrum156
招募中
4 期
Trial to study the effects of two iron preparations in patients with iron deficiency anaemia (IDA)CTRI/2011/10/002097none200
招募中
不适用
Point of CARE testing in a general practice setting trialHyperlipidaemia and anticoagulantm therapyMetabolic and Endocrine - DiabetesDiet and Nutrition - Other diet and nutrition disordersDiabetesACTRN12605000272695Department of General Practice, The University of Adelaide6,836
进行中（未招募）
1 期
Controlled and randomised trial to assess the safety and efficacy of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in hospital healthcare personnel (Sanitarios sin COVID-19).SARS-CoV-2 infection (COVID-19)MedDRA version: 23.0Level: PTClassification code 10051905Term: Coronavirus infectionSystem Organ Class: 10021881 - Infections and infestationsEUCTR2020-001704-42-ESIDIVAL Instituto de Investigación Sanitaria Valdecilla450